-
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Global Respiratory Care Devices Market Outlook
"The Respiratory Care Devices Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031."
Respiratory disease includes any diseases and disorders of the airway and lungs that affect human respiration. Respiratory care devices help remove mucus from the respiratory airway and improve pulmonary function.
Factors such as high prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), tuberculosis, asthma and pneumonia, rising urbanization and pollution levels, increasing incidence of pre-term births, increasing geriatric population, high prevalence of smokers, and changing lifestyle are fueling the growth of global respiratory care devices market. In addition, rising demand for cutting-edge technologies, increasing per capita income and rising demand for respiratory devices in private sector hospitals and clinics, are other factors attributed to market growth.
However, lack of awareness about respiratory conditions results in a large volume of the global population being underdiagnosed and undertreated. Harmful effects of certain respiratory care devices on neonates, high costs associated with the purchase and operation, and increasing sophistication of devices are other major challenges in the market.
In 2015, therapeutic devices segment accounted for largest revenue share in the global respiratory care devices market. Factors contributing to market growth include increasing tobacco smoking globally and rising pollution levels. Among the end user segments, the hospitals segment accounted for largest revenue share contribution to the global respiratory care devices market the same year. Growth of this segment is attributed to increasing investments by hospitals to purchase high-priced instruments as well as rising availability of trained professionals to operate respiratory care devices.
North America market dominates the global respiratory care devices market and is expected to continue its dominance during the forecast period owing to increasing geriatric population and increasing respiratory disorders such as sleep apnea, asthma, lung cancer, and Chronic Obstructive Pulmonary Disorder. Asia Pacific market is expected to register high growth rates during the forecast period.
Global respiratory devices market is segmented and further sub-segmented as follows:
Global respiratory care devices market segmentation, By Product/Device:
- Therapeutic Devices
- Positive Airway Pressure (PAP) Devices
- Masks
- Oxygen Concentrators
- Inhalers
- Reusable Resuscitators
- Nitric Oxide Delivery Units
- Oxygen Hoods
- Ventilators
- Nebulizers
- Humidifiers
- Monitoring Devices
- Gas Analyzers
- Capnographs
- Pulse Oximeters
- Diagnostic Devices
- Spirometers
- Polysomnography (PSG) Devices
- Peak Flow Meters
- Consumables & Accessories
- Disposable Resuscitators
- Tracheostomy Tubes
- Nasal Cannulas
- Disposable Masks
- Other Consumables and Accessories
Global Respiratory care devices market segmentation, by disease/disorder:
- Chronic Obstructive Pulmonary Disease (COPD)
- Sleep Apnea
- Asthma
- Infectious Diseases
- Lung cancer
- Pulmonary fibrosis
- Pulmonary embolism
- Cystic fibrosis
- Allergies
Global Respiratory care devices market segmentation, by End User:
- Hospitals
- Home Care
- Ambulatory Care
Global Respiratory care devices market segmentation, by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn - Therapeutic Devices
- 3M
- AstraZeneca PLC
- GE Healthcare
- GlaxoSmithKline
- Medtronic
- Philips Healthcare
- ResMed, Inc.
- Medtronic plc
- Masimo Corporation
- Fisher & Paykel Healthcare Corporation Limited
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!